HIGHLIGHTS
- who: Vol and collaborators from the (UNIVERSITY) have published the research: MOLECULAR DOCKING OF PHYTOCHEMICALS AS INHIBITORS OF EGFR IN NON-SMALL CELL LUNG CANCER, in the Journal: (JOURNAL)
SUMMARY
Even though lung cancer has been eclipsed by breast cancer as the most often occurring cancer worldwide, it remains a primary cause of cancer death. In the year 2020, a projected 2,206,771 new lung cancer cases will be diagnosed worldwide, with 1,796,144 deaths attributable to lung cancer. Small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.